Skip to main content

Advertisement

Log in

Islet cell transplantation for the treatment of type 1 diabetes in the USA

  • Topics
  • HBP treatment using cell transplantation in the near future
  • Published:
Journal of Hepato-Biliary-Pancreatic Surgery

Abstract

Islet cell transplantation (ICTx) is one of the most effective treatments for type 1 diabetes and is less invasive compared to whole organ transplantation. The US has been the leader in the research and clinical applications of ICTx for the last 40 years. ICTx requires complex procedures, including pancreas procurement and preservation; pancreas digestion; islet purification; and transplantation. Even with the dramatic progresses in each of the procedures listed above, there are still challenges to make ICTx the standard therapy. These challenges are: (1) obtaining enough islets from a single donor and (2) preventing graft loss due to allogenic rejection and recurrence of autoimmune islet destruction. A new preservation strategy for pancreata and pancreatic ducts using ET-Kyoto solution as well as a new islet purification method using iodixanol has substantially improved islet yields. Continuous research to improve the efficacy of islet isolation will solve the issue of obtaining enough islets from a single donor. Immunological tolerance is an ideal solution for the issue of rejection and autoimmune recurrence and a regulatory T cell strategy seems promising. Moreover, the SUITO index is a simple and powerful tool to assess engrafted islet mass and is, therefore, useful for evaluating the efficacy of new immunosuppressant strategies. Once ICTx becomes a standard treatment, the donor shortage will become the next challenge. Marginal or living donor islet transplantations could help alleviate this issue; however, bio-artificial islet transplantation with animal islets could be the ultimate solution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230–8.

    Article  PubMed  CAS  Google Scholar 

  2. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. 5-year follow-up after clinical islet transplantation. Diabetes. 2005;54:2060–9.

    Article  PubMed  CAS  Google Scholar 

  3. Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Nagata H, Yonekawa Y, et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet. 2005;365:1642–4.

    Article  PubMed  CAS  Google Scholar 

  4. Poggioli R, Faradji RN, Ponte G, Betancourt A, Messinger S, Baidal DA, et al. Quality of life after islet transplantation. Am J Transplant. 2006;6:371–8.

    Article  PubMed  CAS  Google Scholar 

  5. Hakim N, Stratta R, Gray D. Pancreas and islet transplantation. NY: Oxford University Press; 2002. p. 305–23.

    Google Scholar 

  6. Najarian JS, Sutherland DER, Matas AJ, Steffes MW, Simmons RL, Goetz FC. Human islet transplantation: a preliminary report. Transplant Proc. 1977;9:233–6.

    PubMed  CAS  Google Scholar 

  7. Davidson MN, Devney P. Attitudinal barriers to organ donation among black Americans. Transplant Proc. 1991;23:2531–2.

    PubMed  CAS  Google Scholar 

  8. Gruessner RWG, Sutherland DER. Transplantation of pancreas. NY: Springer; 2004. p. 111–25.

    Google Scholar 

  9. Sutherland DER, Moudry KC. Report of the International Pancreas Transplant Registry. Clin Transplant. 1987;63–101.

  10. D’Alessandro AM, Sollinger HW, Hoffman RM, et al. Experience with Belzer UW cold storage solution in simultaneous pancreas-kidney transplantation. Transplant Proc. 1990;22:532–4.

    PubMed  CAS  Google Scholar 

  11. D’Alessandro AM, Kalayoglu M, Sollinger HW, Pisch JD, Southard JH, Belzer FO. Current status of organ preservation with University of Wisconsin solution. Arch Pathol Lab Med. 1991;115:306–10.

    PubMed  CAS  Google Scholar 

  12. D’Alessandro AM, Stratta RJ, Sollinger HW, Kalayoglu M, Ploeg RJ, Blezer FO. Use of UW solution in pancreas transplantation. Diabetes. 1989;38(Suppl I):7–9.

    PubMed  CAS  Google Scholar 

  13. Moskalewaski S. Isolation and culture of the islets of Langerhans of the guinea pig. Gen Comp Endocrinol. 1965;5:342–53.

    Article  Google Scholar 

  14. Lacy PE, Kostinovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 1967;16:35–9.

    PubMed  CAS  Google Scholar 

  15. Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes. 1989;38(Suppl 1):140–2.

    PubMed  Google Scholar 

  16. Lindall A, Steffes M, Sorenson R. Immunoassayable content of subcelluar fractions of rat islets. Endocrinology. 1969;85:218–23.

    Article  PubMed  CAS  Google Scholar 

  17. Lake SP, Bsssett PD, Larkins A, et al. Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell processor. Diabetes. 1989;38(Suppl I):143–5.

    PubMed  CAS  Google Scholar 

  18. Hering BJ, Muench KP, Schelz J, Amelang D, Heitfeld M, Bretzel RG, et al. The evaluation of neutral density separation utilizing Ficoll-sodium diatrizoate and Nycodenz and centrifugal elutriation in the purification of bovine and canine islet preparations. Horm Metab Res Suppl. 1990;25:57–63.

    PubMed  CAS  Google Scholar 

  19. Papalois VE, Hakim NS. Pancres transplantation. In: Hakim NS, editor. Induction to organ transplantation. London: Imperial College Press; 1997. p. 189–200.

    Google Scholar 

  20. Ihm SH, Matsumoto I, Sawada T, Nakano M, Zhang HJ, Ansite JD, et al. Effect of donor age on function of isolated human islets. Diabetes. 2006;55(5):1361–8.

    Article  PubMed  CAS  Google Scholar 

  21. Balamurugan AN, Chang Y, Bertera S, Sands A, Shankar V, Trucco M, et al. Suitability of human juvenile pancreatic islets for clinical use. Diabetologia. 2006;49(8):1845–54.

    Article  PubMed  CAS  Google Scholar 

  22. Matsumoto S, Rigley TH, Qualley SA, Kuroda Y, Reems JA, Stevens RB. Efficacy of the oxygen-charged static two-layer method for short-term pancreas preservation and islet isolation from nonhuman primate and human pancreata. Cell Transplant. 2002;11:769–77.

    PubMed  Google Scholar 

  23. Matsumoto S, Kuroda Y. Perfluorocarbon for organ preservation before transplantation. Transplantation. 2002;74:1804–9.

    Article  PubMed  CAS  Google Scholar 

  24. Matsumoto S, Kandaswamy R, Sutherland DE, Hassoun A, Hiraoka K, Sageshima J, et al. Clinical application of the two-layer (University of Wisconsin solution/perfluorochemical plus O2) method of pancreas preservation before transplantation. Transplantation. 2000;70:771–4.

    Article  PubMed  CAS  Google Scholar 

  25. Brandhorst D, Iken M, Brendel MD, Bretzel RG, Brandhorst H. Successful pancreas preservation by a perfluorocarbon-based one-layer method for subsequent pig islet isolation. Transplantation. 2005;79:433–7.

    Article  PubMed  Google Scholar 

  26. Matsumoto S, Noguchi H, Yonekawa Y, Okitsu T, Iwanaga Y, Liu X, et al. Pancreatic islet transplantation for treating diabetes. Expert Opin Biol Ther. 2006;6:23–37.

    Article  PubMed  CAS  Google Scholar 

  27. Lakey JR, Warnock GL, Shapiro AM, Korbutt GS, Ao Z, Kneteman NM, et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant. 1999;8:285–92.

    PubMed  CAS  Google Scholar 

  28. van der Burg MP, Basir I, Bouwman E. No porcine islet loss during density gradient purification in a novel iodixanol in University of Wisconsin solution. Transplant Proc. 1998;30:362–3.

    Article  PubMed  Google Scholar 

  29. Matsumoto S, Zhang HJ, Gilmore T, van der Burg MP, Sutherland DE, Hering BJ. Large-scale isopycnic islet purification utilizing non-toxic, endotoxin-free media facilitates immediate single-donor pig islet allograft function. Transplantation. 1998;66:S30.

    Article  Google Scholar 

  30. Matsumoto S, Shibata S, Kirchhof N, Hiraoka K, Sageshima J, Zhang XW, et al. Immediate reversal of diabetes in primates following intraportal transplantation of porcine islets purified on a new histidine-lactobionate-iodixanol gradient. Transplantation. 1999;67:S220.

    Article  Google Scholar 

  31. Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Nagata H, Yonekawa Y, et al. Successful islet transplantation from non-heart-beating donor pancreata using modified Ricordi islet isolation method. Transplantation. 2006;82:460–5.

    Article  PubMed  Google Scholar 

  32. Okitsu T, Matsumoto S, Iwanaga Y, Noguchi H, Nagata H, Yonekawa Y, et al. Kyoto islet isolation method: the optimized one for non-heart-beating donors with highly efficient islet retrieval. Transplant Proc. 2005;37:3391–2.

    Article  PubMed  CAS  Google Scholar 

  33. Matsumoto S, Noguchi H, Naziruddin B, Onaca N, Jackson A, Hatanaka N, et al. Improvement of pancreatic islet cell isolation for transplantation. Proc (Bayl Univ Med Cent). 2007;20:357–62.

    Google Scholar 

  34. Kemp CB, Knight MJ, Scharp DW, Ballinger WF, Lacy PE. Effect of transplantation site on the results of pancreatic islets isografts in diabetic rats. Diabetologia. 1973;9:486–91.

    Article  PubMed  CAS  Google Scholar 

  35. Naji SA, Shapiro AM. Islet transplantation in patients with diabetes mellitus: choice of immunosuppression. BioDrugs. 2004;18:315–28.

    Article  Google Scholar 

  36. Ikemoto T, Tashiro S, Yasutomo K, Kishihara K, Kurita N, Miyake H. Donor-specific tolerance induced by simultaneous allogeneic islet transplantation with CD4 + CD25 + T-cells into hepatic parenchyma in mice. J Med Invest. 2004;51:178–85.

    Article  PubMed  Google Scholar 

  37. Liu C, Noorchashm H, Sutter AJ, et al. B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in non-human primates. Nat Med. 2007;13(11):1295–8.

    Article  PubMed  CAS  Google Scholar 

  38. Nancy EP, Thomas GM, John PM, et al. Blockade of CD 40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance. J Immunol. 2003;170:3015–23.

    Google Scholar 

  39. Truong W, Plester JC, Hancock WW, Merani S, Murphy TL, Murphy KM, et al. Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts. Am J Transplant. 2007;7:2663–74.

    Article  PubMed  CAS  Google Scholar 

  40. Nasr IW, Wang Y, Gao G, Deng S, Diggs L, Rothstein DM, et al. Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells. J Immunol. 2005;174:6161–8.

    PubMed  CAS  Google Scholar 

  41. Kumagai N, O’Neil JJ, Barth RN, LaMattina JC, Utsugi R, Moran SG, et al. Vascularized islet-cell transplantation in miniature swine I. Preparation of vascularized islet kidneys. Transplantation. 2002;74:1223–30.

    Article  PubMed  CAS  Google Scholar 

  42. Sakonju I, Taura Y, Nakaichi M, Nakama S, Kagabu S. Intrauterine transplantation of isogenic pancreatic islets in experimental diabetic rats. J Vet Med Sci. 1994;56:729–33.

    PubMed  CAS  Google Scholar 

  43. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.

    Article  PubMed  CAS  Google Scholar 

  44. Ikemoto T, Yamaguchi T, Morine Y, Imura S, Soejima Y, Fujii M, et al. Clinical roles of increased populations of Foxp3 + CD4 + T cells in peripheral blood in advanced pancreatic cancer. Pancreas. 2006;33:386–90.

    Article  PubMed  Google Scholar 

  45. Matsumoto S, Noguchi H, Hatanaka N, Kobayashi N, Jackson A, Naziruddin B, et al. Estimation of donor usability for islet isolation with the modified Ricordi method. Transplant Proc. 2008;40:362–3.

    Article  PubMed  CAS  Google Scholar 

  46. Matsumoto S, Yamada Y, Okitsu T, Iwanaga Y, Noguchi H, Yonekawa Y, et al. Simple evaluation of engraftment by secretory unit of islet transplant objects for living donor and cadaveric donor fresh or cultured islet transplantation. Transplant Proc. 2005;37:3435–7.

    Article  PubMed  CAS  Google Scholar 

  47. Yamada Y, Hukuda K, Fujimoto S, Hosokawa M, Tsukiyama K, Nagashima K, et al. SUIT, secretory units of islets in transplantation: an index for therapeutic management of islet transplanted patients and its application to type 2 diabetes. Diabetes Res Clin Pract. 2006;74:222–6.

    Article  PubMed  CAS  Google Scholar 

  48. Matsumoto S, Noguchi H, Hatanaka N, Kobayashi N, Jackson A, Naziruddin B, et al. Evaluation of engraftment after single islet transplantation from a brain-dead donor by the secretory unit of islet transplant objects (SUITO) index. Transplant Proc. 2008;40:364–6.

    Article  PubMed  CAS  Google Scholar 

  49. Noguchi H, Yamada Y, Okitsu T, Iwanaga Y, Nagata H, Kobayashi N, et al. Secretory unit of islet in transplantation and engrafted islet rate indexes are useful for evaluating single islet transplantation. Cell Transplant. 2008;17:121–8.

    Article  PubMed  Google Scholar 

  50. Ichii H, Sakuma Y, Pileggia A, Fraker C, Alvarez A, Montelongo J, et al. Shipment of human islets for transplantation. Am J Transplant. 2007;7:1010–20.

    Article  PubMed  CAS  Google Scholar 

  51. Valdes-Gonzales RA, White DJG, Dorntes LM, Teran L, Garibay-Nieto GN, Brancho-Blanchet E, et al. Three-year follow-up of a type 1 diabetes mellitus patient with an islet xenotransplant. Clin Transplant. 2007;21:352–7.

    Article  Google Scholar 

Download references

Acknowledgments

We thank Dr. Carson Harrod for his careful review of this manuscript. This research is partly funded by All Saints Health Foundation, Otsuka Pharmaceutical Factory Inc., and the Juvenile Diabetes Research Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shinichi Matsumoto.

About this article

Cite this article

Ikemoto, T., Noguchi, H., Shimoda, M. et al. Islet cell transplantation for the treatment of type 1 diabetes in the USA. J Hepatobiliary Pancreat Surg 16, 118–123 (2009). https://doi.org/10.1007/s00534-008-0019-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-008-0019-9

Keywords

Navigation